Home
Coeliac Disease Study Wellington TAK

Coeliac Disease Study

Are you living with coeliac disease? Are you frustrated with the impact it has on your life? Join our research study to help find an effective treatment for coeliac disease.

Description

What to expect

Study details

Ages

18 - 75 years old

Duration

Up to 31 weeks

Compensation

Participants will be reimbursed for study visits and reasonable study-related travel expenses

Eligibility Criteria

You may be eligible to take part if you:

Adults aged 18 - 75 years

Have well-controlled Coeliac disease confirmed by a biopsy

Have been following a gluten free diet as best as you can for at least six months

Test positive for specific genetic markers (HLA-DQ2 and/or HLA-DQ8) during the screen tests.

You will be excluded from the study if you:

Have other inflammatory gastrointestinal or systemic autoimmune diseases (e.g., Inflammatory Bowel Disease, Colitis)

Are currently using or have used systemic immunosuppressants or corticosteroids, such as predsnisone, in the past 12 weeks

Other exclusion criteria may apply

Description

Coeliac disease is an autoimmune disorder triggered by eating gluten, found in wheat, rye, and barley, in genetically predisposed individuals. When gluten is not fully digested, it triggers an immune response that leads to damage in the intestine and can result in symptoms and complications like nutritional deficiencies, skin rashes, and a higher risk of other autoimmune diseases.

The only current treatment is a strict, lifelong gluten-free diet, which is very challenging and can still result in accidental gluten consumption and ongoing symptoms.

What to expect

Momentum is running a clinical research study testing a new investigational treatment that aims to prevent immune cells from reacting to gluten in people with Coeliac Disease.

The study involves three doses which consist of at least one dose of the study medication and a placebo and several gluten challenges.

The study lasts up to 31 weeks with 6 weeks of initial screening, followed by the study treatment on 3 occasions over 24 weeks, and 1 month of follow-up after the treatment ends.

Apply now

Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.

We collect personal information, such as your name, address and contact details, and details of your medical conditions, that enables us to identify if you may be eligible to participate in a current or future study. On occasion we may also contact people on our database by email, with general news and information relevant to our studies and volunteers. By submitting this form you agree to receive email and text notifications about this and other enrolling studies. You can unsubscribe or opt out at any time. We do not sell, share or distribute our database under any circumstances.

We will collect this information directly from you. If you consent to release of medical records, we will obtain medical information from other agencies on your behalf if these are required for your participation in any clinical study at Momentum Clinical Research.

Security of your information is important. Personal information collected is stored by third party data storage providers. We believe these providers offer safe and secure systems.

All information we collect about you will be treated with confidentiality and can be accessed only by Momentum Clinical Research employees.

By completing our online enrolment form, or any other forms we send you, you agree to us holding your personal details within our databases.

Under the Privacy Act 2020, you may ask if we hold personal information on you, you may request access to the information we hold, and you may ask for correction of your personal information. You can ask to be removed from our contact list at any time.

There is no obligation for you to participate in a study that we contact you about. If you decline to participate in a study, that will not affect your eligibility for participation in another study.

Home
Coeliac Disease Study Wellington TAK

Coeliac Disease Study

Are you living with coeliac disease? Are you frustrated with the impact it has on your life? Join our research study to help find an effective treatment for coeliac disease.

Description

What to expect

Study details

Ages

18 - 75 years old

Duration

Up to 31 weeks

Compensation

Participants will be reimbursed for study visits and reasonable study-related travel expenses

Eligibility Criteria

You may be eligible to take part if you:

Adults aged 18 - 75 years

Have well-controlled Coeliac disease confirmed by a biopsy

Have been following a gluten free diet as best as you can for at least six months

Test positive for specific genetic markers (HLA-DQ2 and/or HLA-DQ8) during the screen tests.

You will be excluded from the study if you:

Have other inflammatory gastrointestinal or systemic autoimmune diseases (e.g., Inflammatory Bowel Disease, Colitis)

Are currently using or have used systemic immunosuppressants or corticosteroids, such as predsnisone, in the past 12 weeks

Other exclusion criteria may apply

Description

The only current treatment is a strict, lifelong gluten-free diet, which is very challenging and can still result in accidental gluten consumption and ongoing symptoms.

What to expect

Momentum is running a clinical research study testing a new investigational treatment that aims to prevent immune cells from reacting to gluten in people with Coeliac Disease.

The study involves three doses which consist of at least one dose of the study medication and a placebo and several gluten challenges.

The study lasts up to 31 weeks with 6 weeks of initial screening, followed by the study treatment on 3 occasions over 24 weeks, and 1 month of follow-up after the treatment ends.

Apply now

Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.

We collect personal information, such as your name, address and contact details, and details of your medical conditions, that enables us to identify if you may be eligible to participate in a current or future study. On occasion we may also contact people on our database by email, with general news and information relevant to our studies and volunteers. By submitting this form you agree to receive email and text notifications about this and other enrolling studies. You can unsubscribe or opt out at any time. We do not sell, share or distribute our database under any circumstances.

We will collect this information directly from you. If you consent to release of medical records, we will obtain medical information from other agencies on your behalf if these are required for your participation in any clinical study at Momentum Clinical Research.

Security of your information is important. Personal information collected is stored by third party data storage providers. We believe these providers offer safe and secure systems.

All information we collect about you will be treated with confidentiality and can be accessed only by Momentum Clinical Research employees.

By completing our online enrolment form, or any other forms we send you, you agree to us holding your personal details within our databases.

Under the Privacy Act 2020, you may ask if we hold personal information on you, you may request access to the information we hold, and you may ask for correction of your personal information. You can ask to be removed from our contact list at any time.

There is no obligation for you to participate in a study that we contact you about. If you decline to participate in a study, that will not affect your eligibility for participation in another study.